S. Ortiz-Vega

发表

Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency*

J. Avruch, Samuel Long, S. Ortiz-Vega, 2005, Journal of Biological Chemistry.

Recent advances in the regulation of the TOR pathway by insulin and nutrients

J. Avruch, Samuel Long, S. Ortiz-Vega, 2005, Current opinion in clinical nutrition and metabolic care.

Association of mSin1 with mTORC2 Ras and Akt reveals a crucial domain on mSin1 involved in Akt phosphorylation.

S. Ortiz-Vega, Yenshou Lin, C. Chien, 2017, Oncotarget.

The Mechanism of Insulin-stimulated 4E-BP Protein Binding to Mammalian Target of Rapamycin (mTOR) Complex 1 and Its Contribution to mTOR Complex 1 Signaling*

J. Avruch, N. Oshiro, S. Ortiz-Vega, 2011, The Journal of Biological Chemistry.

Activation of mTORC1 in two steps: Rheb-GTP activation of catalytic function and increased binding of substrates to raptor.

J. Avruch, U. Kikkawa, N. Oshiro, 2009, Biochemical Society transactions.

Activation of mTORC 1 in two steps : Rheb-GTP activation of catalytic function and increased binding of substrates to raptor 1

J. Avruch, U. Kikkawa, N. Oshiro, 2009 .

Regulation of TOR Complex 1 by Amino Acids Through Small GTPases

J. Avruch, N. Oshiro, Samuel Long, 2010 .

The Rheb Switch 2 Segment Is Critical for Signaling to Target of Rapamycin Complex 1*

J. Avruch, Samuel Long, S. Ortiz-Vega, 2007, Journal of Biological Chemistry.

Rheb Binds and Regulates the mTOR Kinase

Joseph Avruch, J. Avruch, Samuel Long, 2005, Current Biology.

Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras.

J. Avruch, S. Ortiz-Vega, M. Praskova, 2004, The Biochemical journal.

Regulation of the MST 1 kinase by autophosphorylation , by the growth inhibitory proteins , RASSF 1 and NORE 1 , and by Ras

J. Avruch, S. Ortiz-Vega, M. Praskova, 2004 .

The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1

J. Avruch, G. Pfeifer, S. Ortiz-Vega, 2002, Oncogene.

Amino acid regulation of TOR complex 1.

J. Avruch, Samuel Long, S. Ortiz-Vega, 2009, American journal of physiology. Endocrinology and metabolism.

Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase

J. Avruch, Y. Lin, Samuel Long, 2006, Oncogene.

Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases.

J. Avruch, S. Ortiz-Vega, M. Praskova, 2006, Methods in enzymology.

The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1

J. Avruch, G. Pfeifer, S. Ortiz-Vega, 2002, Oncogene.

Association of mSin1 with mTORC2 Ras and Akt reveals a crucial domain on mSin1 involved in Akt phosphorylation

S. Ortiz-Vega, Yenshou Lin, C. Chien, 2017, Oncotarget.

Prostaglandin E2 both stimulates and inhibits adenyl cyclase on platelets: comparison of effects on cloned EP4 and EP3 prostaglandin receptor subtypes.

S. Ortiz-Vega, M. Bastepe, B. Ashby, 1996, Prostaglandins.

The Mechanism of Insulin-stimulated 4E-BP Protein Binding to Mammalian Target of Rapamycin (mTOR) Complex 1 and Its Contribution to mTOR Complex 1 Signaling*

J. Avruch, N. Oshiro, S. Ortiz-Vega, 2011, The Journal of Biological Chemistry.

Human prostacyclin receptor: cloning and co-expression with EP3 prostaglandin receptor.

S. Ortiz-Vega, B. Ashby, 1997, Advances in experimental medicine and biology.

Amino acid regulation of TOR complex 1.

J. Avruch, Samuel Long, S. Ortiz-Vega, 2009, American journal of physiology. Endocrinology and metabolism.